Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group
CONCLUSIONS: Prognosis of LGESS is generally good; however, stage IV, incomplete surgery, and PgR-negative tumors are associated with poor prognosis. Adjuvant chemotherapy may be useful for HGESS. Prognosis of UUS is extremely poor, even with adjuvant chemotherapy.PMID:37478616 | DOI:10.1016/j.ygyno.2023.07.002
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Akira Kikuchi Hiroshi Yoshida Hitoshi Tsuda Shin Nishio Shiro Suzuki Kazuhiro Takehara Nao Kino Toshiyuki Sumi Kazuyoshi Kato Masatoshi Yokoyama Kazuto Nakamura Masashi Takano Shinya Sato Hisamori Kato Masato Tamate Koji Horie Tomoyasu Kato Atsuhiko Sakam Source Type: research
More News: Cancer & Oncology | Chemotherapy | Endometrial Cancer | Genetics | Japan Health | Sarcomas | Study | Uterine Sarcoma